The global Vaccine Contract Manufacturing market size is expected to be worth around US$ 14.0 billion by 2030, according to a new report by Vision Research Reports.
The global Vaccine Contract Manufacturing market size was valued at US$ 11.8 billion in 2020 and is anticipated to grow at a CAGR of 19.3% during forecast period 2021 to 2030.
The market is anticipated to witness significant growth over the coming years thanks to rising demand for vaccine development from the private sector as well as governments in industrialized and developing countries.
Vaccine contract services offer cost-saving benefits to their clients. They also help save time in the operations and management of a production and research facility. These advantages associated with Contract Manufacturing Organizations (CMOs) are expected to benefit emerging players, start-ups, and small players who lack adequate facilities and resources required for vaccine development.
An increase in pricing pressure, regulatory challenges, and patent expiration in recent times are expected to adversely impact the market. Contract services are considered “strategic competitive weapons” among vaccine manufacturers as they help overcome the aforementioned issues.
A number of international healthcare organizations are engaged in estimating and predicting the number of goods as well as the financial need required for conducting immunization programs. Some of the factors considered for this estimation are the number of vaccines, estimated time of delivery, product type, and vial size. The participation of international healthcare organizations in vaccination programs is expected to positively influence the growth of contract manufacturers.
Attenuated vaccines accounted for the major share owing to their ability to elicit strong cellular and antibody responses. Moreover, a relatively large number of products licensed for oral or intranasal administration are attenuated, contributing to the dominance of this segment. These offer lifetime immunities with just one or two doses. In addition, proper handling conditions, especially with respect to maintenance as well as storage, will continue to drive the segment.
Inactivated inoculations also accounted for a significant share in 2016, as these are safer and relatively more stable than other types. With several products in various phases of clinical research, DNA vaccines are expected to grow at a lucrative pace. With respect to future potential, they hold great promise in alleviating a number of illnesses. The subunit segment is anticipated to witness steady growth over the forecast period owing to ongoing research for the development of recombinant subunit vaccine against Hepatitis C virus.
Vaccine production requires skilled personnel for upstream as well as downstream processing. Contract manufacturing organizations (CMOs) are providing producers expertise and innovative technologies to accelerate the entire production chain. Between the two processes, the downstream segment dominated the market in 2016. This can be attributed to the fact that downstream processing demands robust and sophisticated equipment for efficient product recovery.
As downstream processing includes product recovery and purification steps, it requires immense attention and capital. Hence, a high requirement for enhanced biotechnological tools, capital, and skilled personnel for recovery of the vaccine as the final product is a major factor that has boosted the growth of the segment over the past years.
Downstream workflow is also driven thanks to various research initiatives being undertaken in the field. For instance, the research project conducted by the Max Plank Institute for the development of complete downstream processing for influenza virus is focused on developing chromatographic methods to ensure purity and optimal yields of vaccines.
The upstream process is expected to emerge as the fastest-growing segment in the vaccine contract manufacturing market thanks to rapid advancements in bioprocessing techniques. Moreover, the introduction of single-use technologies in upstream processing by CMOs is expected to enhance the growth of the segment.
The usage and effectiveness of inoculations is not only limited to humans, but to animals as well. The human-use segment captured the largest share in 2016. Widespread vaccination coverage against a wide range of illnesses in humans has led to this segment acquiring the dominant spot in the market.
However, it has been observed that vaccination plays an important role in improving veterinary health as well as preventing diseases in animals. This is sure anticipated to significantly drive the use of CMOs for animal inoculation production. Vaccination reduces the need for antibiotics to treat animals. Moreover, with growth in the human population, demand for animal-based food continues to grow. Hence, the importance of vaccination in the meat-production industry is also expected to increase. These factors are likely to stoke the growth of the segment.
North America accounted for the largest share in this market mainly due to the widespread manufacturing of vaccines in the region, coupled with the growing presence of a substantial number of biopharmaceutical facilities. State and other laws pertaining to the development of vaccines and other biologics in North America, particularly in the U.S. and Canada, are expected to significantly impact the progress of contract manufacturing organizations (CMOs) and contract research organizations (CROs) in the field.
Lonza; FUJIFILM Diosynth Biotechnologies U.S.A., Inc.; Ajinomoto Althea, Inc.; Merck KGaA; Cytovance Biologics; Catalent, Inc.; IDT Biologika GmbH; Albany Molecular Research, Inc.; PRA Health Sciences; ICON plc.; Pharmaceutical Product Development, LLC; Cobra Bio; and Paragon Bioservices, Inc.
Vaccine Type Outlook
Fill & Finish Operations
Analytical & QC studies
Mammalian Expression Systems
Bacterial Expression Systems
Yeast Expression Systems
Baculovirus/Insect Expression Systems
Middle East & Africa
The Vaccine Contract Manufacturing market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Vaccine Contract Manufacturing market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Vaccine Contract Manufacturing market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Vaccine Contract Manufacturing market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Vaccine Contract Manufacturing market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Vaccine Contract Manufacturing capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Vaccine Contract Manufacturing by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Vaccine Contract Manufacturing market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Vaccine Contract Manufacturing market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Vaccine Contract Manufacturing market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Vaccine Contract Manufacturing industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Vaccine Contract Manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Vaccine Contract Manufacturing market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Vaccine Contract Manufacturing market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Vaccine Contract Manufacturing market. These factors have benefited the growth of the global market for Vaccine Contract Manufacturing. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Vaccine Contract Manufacturing. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Vaccine Contract Manufacturing are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Clinical Trial Equipment & Ancillary Solutions Market (By Product: Sourcing, Supply/Logistics, Service, Others; By Phase: Phase I, Phase II, Phase III, Phase IV) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Dental Suction Systems Market (By Product: Wet Suction, Dry Suction; By End-use: Hospitals, Dental Offices) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Dental Caries Detectors Market (By Product: Laser Fluorescent Caries Detector, Fiber Optic Trans-illumination Caries Detector; By End-use: Hospitals, Dental Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Ophthalmic Perimeters Market (By Product: Static, Kinetic, Combination; By End-use: Hospital, Ophthalmic Clinic, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Investigational New Drug CDMO Market (By Product: Small Molecule, Large Molecule; By Service: Contract Development, Contract Manufacturing; By End-use: Pharmaceutical Companies, Biotech Companies, Others (Government, Research Institutes, Academic Institutes, etc.)) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...